The company has developed an innovative and patented technology that allows clinicians to perform minimally invasive intervention through a short transverse incision to the neck. Key benefits include much less pain and faster recovery than current approaches. Secondary benefits may include reduced blood loss, lower rates of transfusion/infection and much shorter hospital stay. The technology aims to provide both improved clinical outcome for patients and economic savings for healthcare providers.

The company’s CoreVista® device has been successfully used in both surgical and transcatheter aortic valve replacement procedures. Other cardiovascular applications are envisaged with similar benefits for patients and healthcare providers.